Compare Bitwise Crypto Industry Innovators ETF (BITQ) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bitwise Crypto Industry Innovators ETF vs Zimmer Biomet Holdings Inc — how do they compare? Bitwise Crypto Industry Innovators ETF trades at $22.55, while Zimmer Biomet Holdings Inc trades at $97.88 (market cap $18.67B). The key difference: Zimmer Biomet Holdings Inc pays a 0.98% dividend while Bitwise Crypto Industry Innovators ETF pays none, and Zimmer Biomet Holdings Inc is trading nearer its 52-week high, Bitwise Crypto Industry Innovators ETF nearer its low. Which is the better fit depends on your goals.
| BITQ | ZBH | |
|---|---|---|
Sector | Crypto-linked | Health |
52-Week High | $30.43 | $107.71 |
52-Week Low | $16.74 | $79.58 |
Market Cap | — | $18.67B |
Enterprise Value | — | $25.74B |
Dividend Yield | — | 0.98% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BITQ is trading at $22.74, up 2.48% today, but technical indicators show a bearish trend with 15 sell signals versus 1 buy signal. The stock faces resistance at $23-$24 while finding support at $22. Key moving averages remain bearish, though oscillators suggest neutral momentum. Financial ratios including P/E, P/S, and ROE are currently unavailable for analysis.
The outlook remains cautious given the bearish technical picture and lack of recent fundamental data. Investment opportunity depends on upcoming earnings clarity and institutional sentiment shifts. Primary risks include market volatility and potential competitive pressures in the company's sector.
Zimmer Biomet (ZBH) trades at $97.9, up 0.12% on the day, with a bullish technical signal from moving averages. The company reported Q2 2026 EPS of $2.07, beating estimates, and raised its 2026 outlook. Revenue growth remains steady, supported by hips, specialty businesses, and technology. Key financials show a P/E of 23.6 and net income margin of 9.48%, while cash flow from operations improved to $1.70B in 2025.
The outlook is positive, with a consensus price target of $103.56 offering ~6% upside. Risks include competitive pressures and margin volatility, but consistent earnings beats and institutional accumulation support a constructive view for long-term investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Bitwise Crypto Industry Innovators ETF
BITQ tracks companies at the forefront of the crypto economy, including miners, equipment suppliers, and financial service providers. It offers indirect exposure to the growth of the broader crypto ecosystem.
Read more on BITQ →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
